Transferrin-bearing polypropylenimine dendrimer for targeted gene delivery to the brain

Sukrut Somani, David R. Blatchford, Owain Millington, M. Lynn Stevenson, Christine Dufès

Research output: Contribution to journalArticle

  • 39 Citations

Abstract

The possibility of using genes as medicines to treat brain diseases is currently limited by the lack of safe and efficacious delivery systems able to cross the blood-brain barrier, thus resulting in a failure to reach the brain after intravenous administration. On the basis that iron can effectively reach the brain by using transferrin receptors for crossing the blood-brain barrier, we propose to investigate if a transferrin-bearing generation 3-polypropylenimine dendrimer would allow the transport of plasmid DNA to the brain after intravenous administration. In vitro, the conjugation of transferrin to the polypropylenimine dendrimer increased the DNA uptake by bEnd.3 murine brain endothelioma cells overexpressing transferrin receptors, by about 1.4-fold and 2.3-fold compared to that observed with the non-targeted dendriplex and naked DNA. This DNA uptake appeared to be optimal following 2h incubation with the treatment. In vivo, the intravenous injection of transferrin-bearing dendriplex more than doubled the gene expression in the brain compared to the unmodified dendriplex, while decreasing the non-specific gene expression in the lung. Gene expression was at least 3-fold higher in the brain than in any tested peripheral organs and was at its highest 24h following the injection of the treatments. These results suggest that transferrin-bearing polypropylenimine dendrimer is a highly promising gene delivery system to the brain.

LanguageEnglish
Pages78-86
Number of pages9
JournalJournal of Controlled Release
Volume188
Early online date14 Jun 2014
DOIs
StatePublished - 28 Aug 2014

Fingerprint

Dendrimers
Transferrin
Brain
Genes
Transferrin Receptors
DNA
Blood-Brain Barrier
Gene Expression
Intravenous Administration
Gene Transfer Techniques
Brain Diseases
poly(propyleneimine)
Intravenous Injections
Plasmids
Iron
Lung
Injections
Therapeutics

Keywords

  • transferrin-bearing
  • polypropylenimine dendrimer
  • targeted gene delivery
  • brain delivery
  • blood-brain barrier

Cite this

Somani, Sukrut ; Blatchford, David R. ; Millington, Owain ; Stevenson, M. Lynn ; Dufès, Christine. / Transferrin-bearing polypropylenimine dendrimer for targeted gene delivery to the brain. In: Journal of Controlled Release. 2014 ; Vol. 188. pp. 78-86
@article{329e5fea91534736beb25c8547145a89,
title = "Transferrin-bearing polypropylenimine dendrimer for targeted gene delivery to the brain",
abstract = "The possibility of using genes as medicines to treat brain diseases is currently limited by the lack of safe and efficacious delivery systems able to cross the blood-brain barrier, thus resulting in a failure to reach the brain after intravenous administration. On the basis that iron can effectively reach the brain by using transferrin receptors for crossing the blood-brain barrier, we propose to investigate if a transferrin-bearing generation 3-polypropylenimine dendrimer would allow the transport of plasmid DNA to the brain after intravenous administration. In vitro, the conjugation of transferrin to the polypropylenimine dendrimer increased the DNA uptake by bEnd.3 murine brain endothelioma cells overexpressing transferrin receptors, by about 1.4-fold and 2.3-fold compared to that observed with the non-targeted dendriplex and naked DNA. This DNA uptake appeared to be optimal following 2h incubation with the treatment. In vivo, the intravenous injection of transferrin-bearing dendriplex more than doubled the gene expression in the brain compared to the unmodified dendriplex, while decreasing the non-specific gene expression in the lung. Gene expression was at least 3-fold higher in the brain than in any tested peripheral organs and was at its highest 24h following the injection of the treatments. These results suggest that transferrin-bearing polypropylenimine dendrimer is a highly promising gene delivery system to the brain.",
keywords = "transferrin-bearing, polypropylenimine dendrimer, targeted gene delivery, brain delivery, blood-brain barrier",
author = "Sukrut Somani and Blatchford, {David R.} and Owain Millington and Stevenson, {M. Lynn} and Christine Duf{\`e}s",
year = "2014",
month = "8",
day = "28",
doi = "10.1016/j.jconrel.2014.06.006",
language = "English",
volume = "188",
pages = "78--86",
journal = "Journal of Controlled Release",
issn = "0168-3659",

}

Transferrin-bearing polypropylenimine dendrimer for targeted gene delivery to the brain. / Somani, Sukrut; Blatchford, David R.; Millington, Owain; Stevenson, M. Lynn; Dufès, Christine.

In: Journal of Controlled Release, Vol. 188, 28.08.2014, p. 78-86 .

Research output: Contribution to journalArticle

TY - JOUR

T1 - Transferrin-bearing polypropylenimine dendrimer for targeted gene delivery to the brain

AU - Somani,Sukrut

AU - Blatchford,David R.

AU - Millington,Owain

AU - Stevenson,M. Lynn

AU - Dufès,Christine

PY - 2014/8/28

Y1 - 2014/8/28

N2 - The possibility of using genes as medicines to treat brain diseases is currently limited by the lack of safe and efficacious delivery systems able to cross the blood-brain barrier, thus resulting in a failure to reach the brain after intravenous administration. On the basis that iron can effectively reach the brain by using transferrin receptors for crossing the blood-brain barrier, we propose to investigate if a transferrin-bearing generation 3-polypropylenimine dendrimer would allow the transport of plasmid DNA to the brain after intravenous administration. In vitro, the conjugation of transferrin to the polypropylenimine dendrimer increased the DNA uptake by bEnd.3 murine brain endothelioma cells overexpressing transferrin receptors, by about 1.4-fold and 2.3-fold compared to that observed with the non-targeted dendriplex and naked DNA. This DNA uptake appeared to be optimal following 2h incubation with the treatment. In vivo, the intravenous injection of transferrin-bearing dendriplex more than doubled the gene expression in the brain compared to the unmodified dendriplex, while decreasing the non-specific gene expression in the lung. Gene expression was at least 3-fold higher in the brain than in any tested peripheral organs and was at its highest 24h following the injection of the treatments. These results suggest that transferrin-bearing polypropylenimine dendrimer is a highly promising gene delivery system to the brain.

AB - The possibility of using genes as medicines to treat brain diseases is currently limited by the lack of safe and efficacious delivery systems able to cross the blood-brain barrier, thus resulting in a failure to reach the brain after intravenous administration. On the basis that iron can effectively reach the brain by using transferrin receptors for crossing the blood-brain barrier, we propose to investigate if a transferrin-bearing generation 3-polypropylenimine dendrimer would allow the transport of plasmid DNA to the brain after intravenous administration. In vitro, the conjugation of transferrin to the polypropylenimine dendrimer increased the DNA uptake by bEnd.3 murine brain endothelioma cells overexpressing transferrin receptors, by about 1.4-fold and 2.3-fold compared to that observed with the non-targeted dendriplex and naked DNA. This DNA uptake appeared to be optimal following 2h incubation with the treatment. In vivo, the intravenous injection of transferrin-bearing dendriplex more than doubled the gene expression in the brain compared to the unmodified dendriplex, while decreasing the non-specific gene expression in the lung. Gene expression was at least 3-fold higher in the brain than in any tested peripheral organs and was at its highest 24h following the injection of the treatments. These results suggest that transferrin-bearing polypropylenimine dendrimer is a highly promising gene delivery system to the brain.

KW - transferrin-bearing

KW - polypropylenimine dendrimer

KW - targeted gene delivery

KW - brain delivery

KW - blood-brain barrier

UR - http://www.sciencedirect.com/science/journal/01683659

UR - http://www.sciencedirect.com/science/article/pii/S0168365914003939

U2 - 10.1016/j.jconrel.2014.06.006

DO - 10.1016/j.jconrel.2014.06.006

M3 - Article

VL - 188

SP - 78

EP - 86

JO - Journal of Controlled Release

T2 - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

ER -